Prot #AAA-III-01: A multicentre, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with (superscript 177)Lu-DOTA(superscript 0)-Tyr(superscript 3)-Octreotate to Octreotide LAR in patients with inoperab

Project: Research project

Project Details

StatusActive
Effective start/end date6/25/136/25/22

Funding

  • Linical U.K. Ltd (Prot #AAA-III-01)
  • Advanced Accelerator Applications S.A. (Prot #AAA-III-01)